Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01858194 · ClinicalTrials.gov registry record · NA

REnal Sympathetic dEnervaTion as an a Adjunct to Catheter-based VT Ablation

A NA study, sponsored by Vivek Reddy.

Completed
Registry status
NA
Development phase
21
Enrollment target

NCT01858194 is a NA study that has completed, run by Vivek Reddy. The registered enrollment target is 21 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01858194, a NA study, has completed, sponsored by Vivek Reddy.

COMPLETED
Registry status
NA
Development phase
21 participants
Enrollment target

Study Summary

Despite significant advances in the management of ventricular arrhythmias through the use of ICD therapy, AADs, and catheter-based ablation strategies, considerable challenges remain. The optimal method for the prevention of recurrent VT following catheter ablation remains unclear. RSDN may be an effective tool for preventing ventricular arrhythmias, and associated ICD therapies, by reducing central sympathetic tone, catecholamine levels, and the renin-angiotensin- aldosterone system and promoting ventricular remodeling. Although RSDN has been shown to reduce the recurrence of VT in a case report of 2 patients suffering from electrical storm, to date no large prospective randomized study has evaluated the impact of RSDN in the prevention of recurrent VT in patients following catheter ablation of VT with ischemic or non-ischemic ventricular dysfunction. This study will specifically evaluate the safety and efficacy of adjunctive RSDN in the prevention of ICD therapy in patients with ischemic or non-ischemic ventricular dysfunction who are to receive a catheter-based VT ablation.

Interventions

  • DEVICE Renal sympathetic denervation
  • DEVICE VT ablation alone

Trial Details

FieldValue
Enrollment Target 21 participants
Start Date 2013-03
Est. Completion 2017-09-01
Phase NA

Sponsor

Vivek Reddy

20 total trials

What the Registry Record Tells You About NCT01858194

The ClinicalTrials.gov registry entry for NCT01858194 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vivek Reddy, which has 20 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Renal sympathetic denervation is the first listed.

NCT01858194 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01858194 about?

NCT01858194 is a clinical study titled "REnal Sympathetic dEnervaTion as an a Adjunct to Catheter-based VT Ablation". Despite significant advances in the management of ventricular arrhythmias through the use of ICD therapy, AADs, and catheter-based ablation strategies, considerable challenges remain. The optimal method for the prevention of recurrent VT following catheter ablation remains unclear. RSDN may be an ef...

What is the current status of trial NCT01858194?

This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2013-03. Estimated completion is 2017-09-01.

What interventions are being tested in trial NCT01858194?

The interventions under investigation include: Renal sympathetic denervation (DEVICE), VT ablation alone (DEVICE).

Who is sponsoring clinical trial NCT01858194?

This trial is sponsored by Vivek Reddy, which has 20 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.